Experts from across the nation describe the best clinical approaches to rheumatologic disease management.
Search results for: macrophage
Systemic Juvenile Idiopathic Arthritis
Changing treatment paradigms in the biologic era
Drug Updates: Citalopram hydrobromide, Statins, and More
Information on new approvals and medication safety
The Mystery of IVIg
Although initially given as replacement therapy for patients with primary and secondary immunodeficiency states, intravenous immunoglobulin (IVIg) has proven to be effective in the treatment of various autoimmune and inflammatory disorders. This success has led to a dramatic increase in the use of IVIg, with its use as an antiinflammatory agent now vastly surpassing its use in the treatment of immunodeficiencies. Even so, the basis for the antiinflammatory activity of IVIg remains unclear.
Link between Autoimmunity and Environmental Exposure Needs Further Research
Rheumatology needs further cost-effective and validated methods to track the connection between environmental exposure and autoimmune diseases, including research on phenotypes, genotypes, the synergy between multiple infectious and noninfectious exposures, the timing of exposure, and the mechanisms involved, according to presenters of “Impact of Environmental Health on Autoimmunity,” a session here at the 2011 ACR/ARHP Annual Scientific Meeting held in Chicago in November 2011.
Old Drugs Can Learn New Tricks
Methotrexate and its mechanism of action
The Microbiome
A voyage to (our inner) Lilliput
T Cells in Systemic Lupus Erythematosus
Progress toward targeted therapy
What Fat Does to Arthritis
The role of adipokines in the pathogenesis of rheumatic diseases
How a Nuclear Molecule Alarms the Immune System
The role of HMGB1 in the pathogenesis of lupus nephritis
- « Previous Page
- 1
- …
- 21
- 22
- 23
- 24
- 25
- …
- 27
- Next Page »